[1] Giouleka S, Zafeirati C, Siargkas A, et al. Intrahepatic cholestasis of pregnancy: a comparative review of guidelines[J]. Obstet Gynecol Surv, 2025, 80(11):717-730. [2] Spiteri D, Grech L, Savona-Ventura C, et al. Intrahepatic cholestasis of pregnancy: a single-centre whole-exome sequencing study in a maltese cohort[J]. Clin Genet, 2025, 108(2):206-211. [3] Jamshidi Kerachi A, Shahlaee M A, Habibi P, et al. Global and regional incidence of intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis[J]. BMC Med, 2025, 23(1):129. [4] Jasak K, Gajzlerska-Majewska W, Jabiry-Zieniewicz Z, et al. Intrahepatic cholestasis of pregnancy: Diagnosis, management, and future directions-A review of the literature[J]. Diagnostics (Basel), 2025, 15(16):2002. [5] Hocaoglu M, Bulut O, Unal I, et al. Early-and late-onset intrahepatic cholestasis of pregnancy: a comparison of maternal and neonatal outcomes[J]. Fetal Pediatr Pathol, 2025, 44(2):114-130. [6] Huang Y, Yao J, Zhao Y, et al. Distinct response to treatment and characteristics of bile acid composition of early-and late-onset intrahepatic cholestasis of pregnancy: a prospective pilot study[J]. Int J Gynaecol Obstet, 2025, 171(2):819-827. [7] Kumar P, Kulkarni A. UDCA therapy in intrahepatic cholestasis of pregnancy?[J]. J Hepatol, 2020, 72(3):586-587. [8] Iqbal M, Muhammad Z, Akhter N, et al. Effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes[J]. Cureus, 2024, 16(10):e70800. [9] Sarker M R, Ramos G A, Ferrara L, et al. Serial total bile acid measurements in intrahepatic cholestasis of pregnancy[J]. Obstet Gynecol, 2025, 145(3):343-345. [10] Zhao Y, Zhang Q, Sheng Y, et al. Preterm birth and stillbirth: total bile acid levels in intrahepatic cholestasis of pregnancy and outcomes of twin pregnancies: a retrospective cohort study from 2014 to 2022[J]. BMC Pregnancy Childbirth, 2025, 25(1):588. [11] Basu S, Običan S G, Bertaggia E, et al. Unresolved alterations in bile acid composition and dyslipidemia in maternal and cord blood after UDCA treatment for intrahepatic cholestasis of pregnancy[J]. Am J Physiol Gastrointest Liver Physiol, 2025, 328(4):G364-G376. [12] Yao L, Zhou J, Tan Z, et al. Total bile acid concentrations and adverse perinatal outcomes in chinese intrahepatic cholestasis of pregnancy including asymptomatic hypercholanemia of pregnancy: a retrospective cohort study[J]. BMC Pregnancy Childbirth, 2025, 25(1):1103. [13] You P, Ding M, Li X, et al. Determining urinary bile acid profiles to predict maternal and neonatal outcomes in patients with intrahepatic cholestasis of pregnancy[J]. Diagnostics (Basel), 2025, 15(6):657. [14] Zhu X, Sun Y, Zhou Y, et al. Clinical significance of serum lipoprotein(a) in the early diagnosis of intrahepatic cholestasis of pregnancy[J]. J Obstet Gynaecol Res, 2025, 51(7):e70002. [15] Gregorc P, Verdenik I, Pečlin P. Evaluating the effect of bile acid levels on maternal and perinatal outcomes in intrahepatic cholestasis of pregnancy: a retrospective study[J]. Diagnostics (Basel), 2025, 15(17):2185. [16] Misra D, Singh N, Faruqi M, et al. Evaluating the utility of liver transaminases as predictors of feto-maternal outcome in lieu of serum bile acids in intrahepatic cholestasis of pregnancy: a prospective observational study[J]. J Obstet Gynaecol India, 2024, 74(2):113-118. [17] Huang H, Gao J, Dong R, et al. Detection of serum lactate dehydrogenase A and its metabolites on placental function in patients with intrahepatic cholestasis of pregnancy[J]. Int Immunopharmacol, 2025, 145:113739. [18] Feng F, Li J, Liao J, et al. Associations of clinical subtypes and bile acid levels of intrahepatic cholestasis of pregnancy with pregnancy outcomes[J]. Sci Rep, 2024,14(1):12185. |